Sparrow Pharmaceuticals
0 followers
Sparrow Pharmaceuticals is developing targeted therapies for conditions of corticosteroid excess - associated with either the natural corticosteroid cortisol due to a tumor or long-term use of a corticosteroid drug such as prednisone. Sparrow's pipeline is led by SPI-62 in Phase 2 clinical developme... Read more
Org chart
Robert Jacks
President & CEO
Robert Jacks
Collapse
David Katz
Chief Scientific Officer
Frank Czerwiec
Chief Medical Officer
Jamie MacPherson
SVP of Regulatory Affairs & Quality Assurance
Jeff Drajesk
VP of Program Management
